Kamlesh Prataprai Oza
About Kamlesh Prataprai Oza
Data last updated:
Kamlesh Prataprai Oza is a Director at Babuline Pharma Private Limited (since 1988), Director at B A And Brothers(Bombay) Private Limited (since 2007) and Director at Berwind Pharmaceuticals Services Private Limited (since 2002), and holds 1 more current directorship. The companies operate in Pharma, Trading and Chemicals. The 4 current companies with reported revenue have a combined latest revenue of ₹3.39 Cr; the largest is Babuline Pharma Private Limited at ₹3.18 Cr (FY 2025). Earlier, Kamlesh Prataprai Oza was a Director at Colorcon Asia Private Limited (1994–2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Babuline Pharma Private Limited U24230MH1981PTC025180 | Director | 31 Dec 1988 | 1981 | ₹3.18 Cr (FY 2025) | Active |
 B A And Brothers(Bombay) Private Limited U24100MH1962PTC012365 | Director | 28 Jul 2007 | 1962 | ₹20.9 Lakh (FY 2025) | Active |
| Berwind Pharmaceuticals Services Private Limited U24231GA2002PTC003111 | Director | 24 Jun 2002 | 2002 | ₹5,940 (FY 2022) | Active |
| Colorcon Pharmaceuticals Services Private Limited U24231GA2002PTC003110 | Director | 24 Jun 2002 | 2002 | ₹5,006 (FY 2025) | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Colorcon Asia Private Limited U01122GA1994PTC003308 | Director | 22 Apr 1994 | 1994 | ₹1,439 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kamlesh Prataprai Oza
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhadresh Navnitrai Oza | 00044208 | Babuline Pharma Private Limited , B A And Brothers(Bombay) Private Limited | Director |
| Bharat Navnitrai Oza | 00042381 | Babuline Pharma Private Limited , B A And Brothers(Bombay) Private Limited | Managing Director |
| Chanakya Bharat Oza | 02410985 | Babuline Pharma Private Limited , B A And Brothers(Bombay) Private Limited | Director |
| Kaushik Kantilal Sheth | 00081460 | Berwind Pharmaceuticals Services Private Limited , Colorcon Pharmaceuticals Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kamlesh Prataprai Oza
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kamlesh Prataprai Oza
Kamlesh Prataprai Oza currently holds 4 directorships: Babuline Pharma Private Limited (Director, since 31 Dec 1988, revenue ₹3.18 Cr (FY 2025)); B A And Brothers(Bombay) Private Limited (Director, since 28 Jul 2007, revenue ₹20.9 Lakh (FY 2025)); Berwind Pharmaceuticals Services Private Limited (Director, since 24 Jun 2002, revenue ₹5,940 (FY 2022)); Colorcon Pharmaceuticals Services Private Limited (Director, since 24 Jun 2002, revenue ₹5,006 (FY 2025)).
Kamlesh Prataprai Oza was first appointed on 31 Dec 1988 as Director at Babuline Pharma Private Limited. The most recent appointment on record is 28 Jul 2007 at B A And Brothers(Bombay) Private Limited.
The 4 current companies of Kamlesh Prataprai Oza that report revenue have a combined latest revenue of ₹3.39 Cr: Babuline Pharma Private Limited ₹3.18 Cr (FY 2025); B A And Brothers(Bombay) Private Limited ₹20.9 Lakh (FY 2025); Berwind Pharmaceuticals Services Private Limited ₹5,940 (FY 2022); Colorcon Pharmaceuticals Services Private Limited ₹5,006 (FY 2025).
Kamlesh Prataprai Oza held 1 earlier board appointment: Colorcon Asia Private Limited (Director, 22 Apr 1994 to 16 Dec 2013).
The current boards of Kamlesh Prataprai Oza's companies include Bhadresh Navnitrai Oza (Babuline Pharma Private Limited), Bharat Navnitrai Oza (Babuline Pharma Private Limited), Chanakya Bharat Oza (Babuline Pharma Private Limited), Kaushik Kantilal Sheth (Berwind Pharmaceuticals Services Private Limited).